NEW YORK (GenomeWeb) – Based on a new study, a team of Swiss researchers has made a case for expanding noninvasive prenatal testing beyond the threecommon trisomies — T21, T18, and T13 — and sex-chromosome anomalies to which many current NIPT assays limit themselves.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.


This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.


This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs. 

Sponsored by

This webinar will be a roundtable discussion on the adoption of a commercial gene panel for tumor profiling at several leading US cancer centers.